Warts
Julia K. Gittler
<p class="MsoNormal" style="mso-pagination: widow-orphan;">Julia K. Gittler, MD, is an attending physician and Assistant Professor at Montefiore-Einstein. Dr. Gittler’s clinical areas of focus include all areas of pediatric dermatology, including eczema, vascular and other birthmarks, acne, genetic skin disorders and other pediatric dermatologic conditions.</p>
<p class="MsoNormal">Dr. Gittler earned her Bachelor of Arts at the University of Pennsylvania College of Arts and Sciences in 2008 and graduated summa cum laude. From 2008 to 2013, she attended the Albert Einstein College of Medicine, receiving her Doctor of Medicine and earning distinction in dermatology research through a research fellowship at the Rockefeller University. Her training also includes completion of a yearlong pediatrics internship at Cohen Children’s Medical Center in 2014, a three-year dermatology residency at New York University in 2017 and a yearlong pediatric dermatology fellowship at Columbia University in 2018.</p>
<p class="MsoNormal" style="mso-pagination: widow-orphan;">Following her clinical interests, Dr. Gittler’s research focus is on pediatric dermatology. Her work has been published in many peer-reviewed journals. She has also shared her research through poster presentations and lectures at regional and national conferences.</p>
<p class="MsoNormal" style="mso-pagination: widow-orphan;">Dr. Gittler is certified in pediatric dermatology by the American Board of Dermatology. She is a member of the American Academy of Dermatology and the Society of Pediatric Dermatology.</p>
Benedict C. Wu
<p>Benedict (Benny) Wu, DO, PhD, is the Director of Inpatient Dermatology and Assistant Professor at Montefiore-Einstein. Dr. Wu’s clinical interests extend to inpatient and complex medical dermatology areas, including connective tissue disorders, autoimmune bullous disorders, immunodermatology, cutaneous presentation of systemic conditions, and cutaneous lymphomas.</p>
<p>After earning his Bachelor of Science in biological sciences from the University of California, Irvine, Dr. Wu attended the University of Medicine and Dentistry of New Jersey, earning his Master of Biomedical Sciences. He later attended Rowan University, earning his Doctor of Philosophy in Cell and Molecular Biology in 2014 and his Doctor of Osteopathic Medicine in 2016. His postdoctoral training began with an internship in internal medicine at Drexel University College of Medicine, followed by a clinical research fellowship at Northwestern University. In 2021, he completed his Dermatology residency at Broward Health in Fort Lauderdale, Florida.</p>
Increasing the diagnostic accuracy of autoantibody-mediated skin diseases.
Prognostic factors in complex medical dermatologic diseases.
<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;"> Dr. Wu’s clinical interests extend to inpatient and complex medical dermatology areas, including connective tissue disorders, autoimmune bullous disorders, immunodermatology, cutaneous presentation of systemic conditions, and cutaneous lymphomas.</span>
<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Wu’s research investigates several questions. His research focus spans from his work in the clinic to the basic sciences. For example, does physical and/or emotional stress significantly exacerbate complex medical dermatoses? In the future, he hopes to examine neutrophil dysfunction at the cellular and molecular level from tissue and blood samples from neutrophil-predominant dermatoses.</span>
<p><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif; color: #212121;">Hopkins ZH, Wu BC, Nousari CH. Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. </span><em><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif; color: #212121;">N Engl J Med</span></em><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif; color: #212121;">. 2021;385(11):1055-1056. doi:10.1056/NEJMc2111763</span></p>
<p><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif; color: #212121;">Nousari Y, Wu BC, Tausk F. From the Caravels to the Wards: Scurvy and Schizophrenia [published online ahead of print, 2021 Jun 8]. <em>J Acad Consult Liaison Psychiatry</em>. 2021;S2667-2960(21)00097-5. doi:10.1016/j.jaclp.2021.05.006</span></p>
<p><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif;">Nousari Y, Wu BC, Valenzuela G. Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome [published online ahead of print, 2021 Apr 29]. <span class="em" style="border: none; vertical-align: baseline;"><em><span style="border: none;"><span style="border: none;">Clin Exp Dermatol</span></span></em></span>. 2021;10.1111/ced.14712. doi:10.1111/ced.14712</span></p>
<p><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif;">Erickson, T. R., Murphrey, M. B., Abu-Zayed, H., Wu, B., Ibler, E., Rangel, S. M., & Paller, A. S. (2020). Transepidermal water loss in the orphan forms of ichthyosis. <span class="em" style="border: none; vertical-align: baseline;"><em><span style="border: none;"><span style="border: none;">Pediatric dermatology</span></span></em></span>, <span class="em" style="border: none; vertical-align: baseline;"><em><span style="border: none;"><span style="border: none;">37</span></span></em></span>(4), 771–773. https://doi.org/10.1111/pde.14221</span></p>
<p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Benedict (Benny) Wu, DO, PhD, is the Director of Inpatient Dermatology and Assistant Professor at Montefiore-Einstein. Dr. Wu’s clinical interests extend to inpatient and complex medical dermatology areas, including connective tissue disorders, autoimmune bullous disorders, immunodermatology, cutaneous presentation of systemic conditions, and cutaneous lymphomas.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">After earning his Bachelor of Science in biological sciences from the University of California, Irvine, in 2006, Dr. Wu attended the University of Medicine and Dentistry of New Jersey, earning his Master of Biomedical Sciences in 2007. He later attended Rowan University, earning his Doctor of Philosophy in Cell and Molecular Biology in 2014 and his Doctor of Osteopathic Medicine in 2016. His postdoctoral training began with an internship in internal medicine at Drexel University College of Medicine in 2017, followed by a clinical research fellowship at Northwestern University in 2018. In 2021, he completed a three-year dermatology residency at Broward Health.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Wu’s research investigates several questions. His research focus spans from his work in the clinic to the basic sciences. For example, does physical and/or emotional stress significantly exacerbate complex medical dermatoses? In the future, he hopes to examine neutrophil dysfunction at the cellular and molecular level from tissue and blood samples from neutrophil-predominant dermatoses. He has shared his research in many oral and poster presentations, as well as in peer-reviewed publications.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Wu is a member of several professional societies, including the American Academy of Dermatology, the Medical Dermatology Society, the Society for Dermatological Hospitalists, and the Society for Investigative Dermatology.</p>
Ellen D. Teplitz
Michel Nassar
Clinical interests include minimally invasive airway surgery and reconstruction, and the medical and surgical management of pediatric hearing loss, including endoscopic ear surgery, cochlear implants and bone anchored hearing aids (BAHA).<quillbot-extension-portal></quillbot-extension-portal>
In addition to his interests in the use of simulation in medical education, Dr. Nassar also has an interest in congenital cytomegalovirus (CMV) and hearing loss, including targeted CMV screening and the use of Valganciclovir for CMV-infected hearing-impaired infants (ValEAR).<quillbot-extension-portal></quillbot-extension-portal>
<p>Michel Nassar, MD, MSc, is Director, AeroDigestive Program at Children’s Hospital at Montefiore, and Co-Director, CranioFacial Clinic and Associate Professor of Otolaryngology at Montefiore-Einstein. Dr. Nassar takes a multidisciplinary approach to patients with complex aerodigestive disease. His clinical interests include minimally invasive airway surgery and reconstruction, and the medical and surgical management of pediatric hearing loss, including endoscopic ear surgery, cochlear implants and bone anchored hearing aids (BAHA). He also has expertise in the medical and surgical management of velopharyngeal disorders.</p><p>Dr. Nassar earned his medical degree at Saint Joseph University in Beirut, Lebanon in 2005. He began his postgraduate training in France, completing an otolaryngology residency at Hotel Dieu de France Hospital in 2010 and his Masters in Surgical Sciences and pediatric otolaryngology fellowship in 2012. He then came to the United States, completing a pediatric otolaryngology fellowship at Cincinnati Children’s Hospital in 2013.</p><p>In addition to his interests in the use of simulation in medical education, Dr. Nassar also has an interest in congenital cytomegalovirus (CMV) and hearing loss, including targeted CMV screening and the use of Valganciclovir for CMV-infected hearing-impaired infants (ValEAR). His work has been shared through peer-reviewed journals and oral presentations. He is also a reviewer for <em>Laryngoscope, the International Journal of Pediatric Otorhinolaryngology and the European Annals of Otorhinolaryngology</em>.</p><p>Dr. Nassar is a member of the American Academy of Otolaryngology–Head and Neck Surgery, the American Academy of Pediatrics and the International Federation of Oto-Rhino-Laryngological Societies. He has been listed among the <em>New York Times</em>’ Super Doctors - Rising Stars.</p>
Beth N. McLellan
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Beth McLellan graduated with honors from Northwestern University and attended medical school at Wayne State University where she graduated with Alpha Omega Alpha honors. She completed an internship in Internal Medicine at Loyola University Health System and her Dermatology residency at Henry Ford Health System in Detroit where she also served as Chief Resident. She currently is a Professor in the Department of Medicine (Dermatology) and has served as Chief of the Division of Dermatology since 2020.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. McLellan specializes in complex medical Dermatology and has a special interest in Supportive Oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair, and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis as well as successful use of bacterial decolonization for prevention of radiation dermatitis. She has published numerous articles and textbook chapters related to Supportive Oncodermatology and is regularly invited to speak at Dermatology and Oncology conferences for physicians and patients including the annual meeting of the American Academy of Dermatology, ASCO, and Gilda's Club.</span></p>
<p class="MsoNormal" style="margin-bottom: 0in; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Playing an active role in the Dermatology Residency, Dr. McLellan is the director of resident research and regularly lectures residents and medical students. She has served as a mentor to many residents and students and directs a year-long Oncodermatology research fellowship for medical students taking a year off for research. Interested medical students can learn more about the fellowship here: https://www.einsteinmed.edu/departments/medicine/divisions/dermatology/…;
<div> </div>
<div> </div>
<div> </div>
<p> </p>
Chemotherapy Side Effects
Scalp Cooling
Dr. McLellan specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.
Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis
<p>Beth N. McLellan, MD, is Chief, Dermatology, Director, Supportive Oncodermatology and Professor, Dermatology at Montefiore Einstein. She specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.</p><p>After earning her Doctor of Medicine at Wayne State University, Dr. McLellan completed an internship in internal medicine at Loyola University Health System and her dermatology residency at Henry Ford Health System where she also served as chief resident and initiated a supportive oncodermatology clinic. Dr. McLellan received additional oncodermatology training at Memorial Sloan Kettering Cancer Center and at the Institut Gustave Roussy in Paris, France.</p><p>Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis. Playing an active role in the Montefiore Einstein Dermatology Residency, Dr. McLellan is the Director of Resident Research and regularly lectures residents and medical students at both dermatology and oncology meetings. She has served as a mentor to many residents and students and directs a year long oncodermatology research fellowship for medical students taking a year off for research. Dr. McLellan has published numerous articles and textbook chapters related to supportive oncodermatology and is regularly invited to speak at dermatology and oncology conferences for physicians and patients, including the annual meeting of the American Academy of Dermatology, American Society of Clinical Oncology and Gilda's Club.</p><p>As part of her commitment to treating the whole patient, Dr. McLellan founded the New York Vitiligo Support Group. She has received awards from the Dermatology Foundation.</p>
Ranon E. Mann
As Program Director my clinical focus is patient care and resident education. My interests surround<br />complex medical dermatology.
Research focus on skin disorders affecting patients who are HIV positive.
Tobi B. Klar
<span style="font-family:Calibri, sans-serif;font-size:16px;">Dr. Klar’s clinical expertise includes general dermatological procedures, as well as more complex procedures such as the treatment of psoriasis and inflammatory dermatoses with phototherapy, topical therapy and biologic therapy.</span>
<span style="font-family:Calibri, sans-serif;font-size:16px;">Dr. Klar’s research interests are in treatment options for acne, psoriasis and eczema.</span>
<p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">Tobi Klar, MD, is an attending physician and Assistant Professor at Montefiore-Einstein. Dr. Klar’s clinical expertise includes general dermatological procedures, as well as more complex procedures such as the treatment of psoriasis and inflammatory dermatoses with phototherapy, topical therapy and biologic therapy. Dr. Klar also treats cancers of the skin including melanoma, basal cell carcinoma and squamous cell carcinoma.<span> </span>She has advanced training and extensive experience treating adults and children for general dermatological conditions, including rashes, acne, rosacea and eczema. She also performs skin cancer screenings and treats premalignant and malignant conditions.</span></p> <p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">After earning her Doctor of Medicine at the State University of New York Downstate in 1981, Dr. Klar continued at the institution for her postdoctoral training, completing her Internal Medicine Internship in 1982, her Internal Medicine Residency in 1983 and her Dermatology Residency in 1986.</span></p> <p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">Dr. Klar’s research interests are in treatment options for acne, psoriasis and eczema. </span></p> <p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">Dr. Klar is board certified and is a member of several professional associations including the Society for Clinical Vascular Surgery, the Society of Vascular Ultrasound and the Peripheral Vascular Surgery Society.</span></p>
Holly E. Kanavy
<p>Dr. Holly Kanavy completed a B.S. in Biochemistry with Departmental Honors in Neuroscience at Stony Brook University and a medical degree at New York College of Osteopathic Medicine, where she received the A.T. Still Memorial Scholarship Award and was a member of the Psi Sigma Alpha National Osteopathic Scholastic Honor Society. Following an internship at North Shore/LIJ Plainview Hospital, Dr. Kanavy completed two fellowships, one in Melanoma Translational Research at NYU Langone Medical Center, and another in Dermatopharmacology at University Hospitals Case Medical Center in Cleveland, Ohio. She then completed a dermatology residency at Saint Barnabas Hospital in the Bronx, serving as chief resident.</p>
<p>Dr. Kanavy is currently active in the study of dermoscopic patterns of acral nevi. She has received several awards and grants, including the A.P. Ublrich Research Award for her work in the study of acral nevi and the Bayer Healthcare Writing Grant Competition for her study of skin cancer chemoprevention. She has contributed to numerous dermatology journals and textbooks, including <em>Archives in Dermatology, Photodermatology, Photoimmunology & Photomedicine, </em><em> Journal of the American Osteopathic College of Dermatology, </em>and<em> Cancer of the Skin.</em></p>
<p><!-- [if gte mso 9]><xml>
<o:OfficeDocumentSettings>
<o:AllowPNG/>
</o:OfficeDocumentSettings>
</xml><![endif]--></p>